Search results for: England
Filter search results
The Impact of Ageing on Health Care Expenditures: Impending Crisis, or Misguided Concern?
1 June 2004
…Hospital and Community Health Services (HCHS) and Family Health Services (FHS) in the National Health Service (NHS) England and Wales, which finds that the age-expenditure relationship has not stayed constant…
Delivering an Outcomes-based NHS: Creating the Right Conditions
1 February 2017
…been adopted by NHS services across England and that brings together commissioners, providers,… This OHE Seminar Briefing summarises a seminar given by Dr Nicholas Hicks, Co-founder and Chief Executive of…
Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
1 March 2017
…marketing authorisation in the EU. These OMPs are most widely accessible in Germany and France. In the other countries between 30% and 60% of OMPs are reimbursed. In England, less…
Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets
1 March 2017
Three EQ-5D value sets (the EQ-5D-3L, crosswalk and EQ-5D-5L) are now available for cost utility analysis in the UK and/or England. The value sets’ characteristics differ, and it is important…
2018 OHE Annual Report to the Charity Commission
1 November 2019
We are pleased to submit the second report to the Charity Commission for England and Wales, OHE’s second since becoming a registered charity in December 2016. OHE obtained its charitable…
NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?
7 January 2020
The National Institute of Health and Care Excellence (NICE) makes recommendations for the use of interventions including medicines in the National Health Service in England based on their clinical and…
2019 OHE Annual Report to the Charity Commission
1 December 2020
We are pleased to submit the third report to the Charity Commission for England and Wales, OHE’s second since becoming a registered charity in December… We are pleased to submit…
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
1 September 2021
…key perceived challenges, better understand the intricacies of the NICE appraisal process and the interplay with NHS England. The case studies include examples of cancer and non-cancer medicines, medicines with…
James Zackheim – 2022 Prize Finalist
18 January 2023
…the development, from concept to production, of cutting–edge, patentable medical education e–tools to improve communication between patients and physicians. Dr. Zackheim graduated from the University of Leeds, England, in 1995,…